Significant Ownership of Pontifax Management 4 G.P. (2015) Ltd.

Signature - Title
/s/ Tomer Kariv - Tomer Kariv, Chief Executive Officer
Location
Herzliya Pituach, Israel
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Pontifax Management 4 G.P. (2015) Ltd..

Notify me when Pontifax Management 4 G.P. (2015) Ltd. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Pontifax Management 4 G.P. (2015) Ltd.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CLYM Climb Bio, Inc. Common Stock, par value $0.0001 per share 7.7% $12,911,822 5,206,380 Pontifax VI G.P. L.P. 27 Jun 2024
LB Pharmaceuticals Inc Common Stock, $0.0001 par value per share 6.3% 1,411,681 Pontifax Management 4 G.P. (2015) Ltd. 12 Sep 2025
KROS Keros Therapeutics, Inc. Common Stock, Par Value $0.0001 Per Share 0% $0 -$75,735,576 0 -100% Pontifax Management 4 GP (2015) Ltd. 15 Oct 2025

Schedules 13D/G Reported by Pontifax Management 4 G.P. (2015) Ltd.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.